CNS Pharmaceuticals, Inc.
CNSP
$4.59
-$0.30-6.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.94M | -5.96M | -3.22M | -2.38M | -4.30M |
| Total Depreciation and Amortization | 1.90K | 1.00K | 700.00 | 1.10K | 1.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.60K | 87.60K | 18.50K | 21.80K | 62.40K |
| Change in Net Operating Assets | 284.00K | 2.82M | 1.03M | -2.99M | 995.90K |
| Cash from Operations | -4.65M | -3.05M | -2.17M | -5.34M | -3.24M |
| Capital Expenditure | -6.20K | -18.20K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.20K | -18.20K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -96.20K | -30.80K | -91.00K | -88.90K | -86.90K |
| Issuance of Common Stock | 500.90K | 501.70K | 800.00 | 4.51M | 9.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -64.10K | -1.50K | 0.00 | 882.00K |
| Cash from Financing | 404.70K | 406.90K | -91.60K | 4.43M | 9.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.25M | -2.66M | -2.27M | -917.70K | 6.59M |